JP2013518606A5 - - Google Patents

Download PDF

Info

Publication number
JP2013518606A5
JP2013518606A5 JP2012552935A JP2012552935A JP2013518606A5 JP 2013518606 A5 JP2013518606 A5 JP 2013518606A5 JP 2012552935 A JP2012552935 A JP 2012552935A JP 2012552935 A JP2012552935 A JP 2012552935A JP 2013518606 A5 JP2013518606 A5 JP 2013518606A5
Authority
JP
Japan
Prior art keywords
seq
sequence
cdr
amino acid
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012552935A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013518606A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/024123 external-priority patent/WO2011100271A2/en
Publication of JP2013518606A publication Critical patent/JP2013518606A/ja
Publication of JP2013518606A5 publication Critical patent/JP2013518606A5/ja
Pending legal-status Critical Current

Links

JP2012552935A 2010-02-09 2011-02-09 新規使用 Pending JP2013518606A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30263610P 2010-02-09 2010-02-09
US61/302,636 2010-02-09
PCT/US2011/024123 WO2011100271A2 (en) 2010-02-09 2011-02-09 Novel uses

Publications (2)

Publication Number Publication Date
JP2013518606A JP2013518606A (ja) 2013-05-23
JP2013518606A5 true JP2013518606A5 (https=) 2013-12-05

Family

ID=44368403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012552935A Pending JP2013518606A (ja) 2010-02-09 2011-02-09 新規使用

Country Status (5)

Country Link
US (1) US20120315267A1 (https=)
EP (1) EP2534256A4 (https=)
JP (1) JP2013518606A (https=)
CA (1) CA2789416A1 (https=)
WO (1) WO2011100271A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104761637B (zh) 2006-03-31 2021-10-15 中外制药株式会社 调控抗体血液动力学的方法
ES2595638T3 (es) 2007-09-26 2017-01-02 Chugai Seiyaku Kabushiki Kaisha Método para modificar el punto isoeléctrico de un anticuerpo mediante la sustitución de aminoácidos en una CDR
KR102057826B1 (ko) 2008-04-11 2019-12-20 추가이 세이야쿠 가부시키가이샤 복수 분자의 항원에 반복 결합하는 항원 결합 분자
EP2647706B1 (en) 2010-11-30 2023-05-17 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
WO2014030750A1 (ja) 2012-08-24 2014-02-27 中外製薬株式会社 マウスFcγRII特異的Fc抗体
SG10201709559PA (en) 2012-08-24 2017-12-28 Chugai Pharmaceutical Co Ltd Fcγriib-specific fc region variant
TWI612059B (zh) * 2013-03-15 2018-01-21 美國禮來大藥廠 泛-ELR<sup>+</sup>CXC趨化因子抗體
JP6574754B2 (ja) 2013-03-19 2019-09-11 ベイジン シェノゲン ファーマ グループ リミテッド エストロゲン受容体関連疾患を処置するための抗体及び方法
CN105246914B (zh) 2013-04-02 2021-08-27 中外制药株式会社 Fc区变体
KR20160021125A (ko) 2013-05-17 2016-02-24 쌩뜨레 나티오날 데 라 르세르쉬 생띠끄 (씨. 엔. 알. 에스) 항-cxcl1, cxcl7 및 cxcl8 항체 및 이들의 용도
KR101860280B1 (ko) 2014-12-19 2018-05-21 추가이 세이야쿠 가부시키가이샤 항-마이오스타틴 항체, 변이체 Fc 영역을 함유하는 폴리펩타이드, 및 사용 방법
KR102605798B1 (ko) 2015-02-05 2023-11-23 추가이 세이야쿠 가부시키가이샤 이온 농도 의존적 항원 결합 도메인을 포함하는 항체, Fc 영역 개변체, IL-8에 결합하는 항체, 및 그들의 사용
WO2017110981A1 (en) 2015-12-25 2017-06-29 Chugai Seiyaku Kabushiki Kaisha Anti-myostatin antibodies and methods of use
EP3494991A4 (en) * 2016-08-05 2020-07-29 Chugai Seiyaku Kabushiki Kaisha COMPOSITION FOR THE PROPHYLAXIS OR TREATMENT OF IL-8 RELATED DISEASES
SG10201607778XA (en) 2016-09-16 2018-04-27 Chugai Pharmaceutical Co Ltd Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use
EP3684811A2 (en) * 2017-08-17 2020-07-29 Massachusetts Institute of Technology Multiple specificity binders of cxc chemokines and uses thereof
CN112119090B (zh) 2018-03-15 2023-01-13 中外制药株式会社 对寨卡病毒具有交叉反应性的抗登革热病毒抗体及使用方法
WO2020218465A1 (ja) * 2019-04-26 2020-10-29 中外製薬株式会社 子宮内膜症の診断方法、病態モニタリング方法及びキット
US12016846B2 (en) 2020-08-19 2024-06-25 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of treating aneurysms
US12553904B2 (en) 2024-05-08 2026-02-17 University of Pittsburgh—of the Commonwealth System of Higher Education Methods of detecting and treating cerebral aneurysms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005313971B2 (en) * 2004-12-08 2011-10-13 Immunomedics, Inc. Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
US7612181B2 (en) * 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
CL2008001071A1 (es) * 2007-04-17 2009-05-22 Smithkline Beecham Corp Metodo para obtener anticuerpo penta-especifico contra il-8/cxcl8, gro-alfa/cxcl1, gro-beta/cxcl2), gro-gama/cxcl3 y ena-78/cxcl5 humanas; anticuerpo penta-especifico; proceso de produccion del mismo; vector, hbridoma o celela que lo comprende; composicion farmceutica; uso para tratar copd, otras enfermedades.

Similar Documents

Publication Publication Date Title
JP2013518606A5 (https=)
JP2016185981A5 (https=)
JP2011087580A5 (https=)
JP2017114866A5 (https=)
JP2012528584A5 (https=)
HRP20150937T1 (hr) Pentaspecifiäśno protutijelo
JP2014012688A5 (https=)
JP2005120106A5 (https=)
FI3527070T3 (fi) Humanisoituja kevytketjuhiiriä
JP2012143232A5 (https=)
JP2009225798A5 (https=)
JP2011155981A5 (https=)
HRP20171194T1 (hr) Trovalentni konstrukti nanotijela protiv ljudskog respiratornog sincicijskog virusa (hrsv) za prevenciju i/ili liječenje infekcija dišnih puteva
JP2016196468A5 (https=)
JP2010502207A5 (https=)
JP2017534262A5 (https=)
IL212047A (en) Human antibody that binds to human igf-1 and igf-2, a dna molecule encoding said antibody, an expression vector containing the dna molecule and a host cell carrying the expression vector, a method for producing said antibody and pharmaceutical composition comprising it for treating disorders
FI3354729T3 (fi) Anti-garp-vasta-aine
FI3088517T3 (fi) Ihmisen Anti-IL-33 neutraloiva monoklonaalinen vasta-aine
JP2013544756A5 (https=)
JP2007045828A5 (https=)
JP2007197439A5 (https=)
JP2010227108A5 (https=)
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
CA2699834A1 (en) Improved anti-il-6 receptor antibody